UPCOMING SESSIONS in ET
Thu, May 28, 2026
5:00 – 6:30 AM Bangkok
90-Minute Extended Session: TTR Inheritance, Genetic Testing & ACT-EARLY Trial Dr. Rachel Campagna Click To Register
UPCOMING SESSIONS in ET
Thu, May 28, 2026 · 5:00 – 6:30 AM Bangkok
90-Minute Extended Session: TTR Inheritance, Genetic Testing & ACT-EARLY Trial
Dr. Rachel Campagna
Click To Register
View all sessions

Clinical And Genetic Profile Of Hereditary Transthyretin (ATTRv) Amyloidosis In The Middle East: A Single-Center Report

Source
Global Cardiology Science And Practice

Abstract

Background and Purpose: Transthyretin (ATTR) amyloidosis, including wild-type (ATTRwt) and hereditary (ATTRv) forms, is a rare but increasingly recognized disease. This first report from the Middle East presents our experience diagnosing ATTRv amyloidosis at the Abdali National Amyloidosis Center

Methods: All referred patients underwent comprehensive evaluation. ATTR amyloidosis was established by a Perugini grade 2 or 3 positive pyrophosphate (PYP) scan, with exclusion of light chain monoclonality by serum and urine immunofixation and free light chain assay. Confirmed cases subsequently underwent genetic testing for TTR mutations